| Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Filling date: 9 Sep 2025 Issue date: 19 May 2020 | 5 Jul 2019 | 19 May 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against CLL and other cancers Filling date: 9 Sep 2025 Issue date: 19 May 2020 | 17 May 2019 | 19 May 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against CLL and other cancers Filling date: 9 Sep 2025 Issue date: 19 May 2020 | 17 May 2019 | 19 May 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 14 May 2020 | 21 Jan 2020 | 14 May 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 14 May 2020 | 16 Dec 2019 | 14 May 2020 |
| Utility: NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME Filling date: 9 Sep 2025 Issue date: 7 May 2020 | 3 Jan 2020 | 7 May 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 7 May 2020 | 30 Oct 2019 | 7 May 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 5 May 2020 | 30 Aug 2019 | 5 May 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 5 May 2020 | 30 Aug 2019 | 5 May 2020 |
| Utility: Immunotherapy against melanoma and other cancers Filling date: 9 Sep 2025 Issue date: 5 May 2020 | 16 Oct 2018 | 5 May 2020 |
| Utility: T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME AGAINST PRAME POSITIVE CANCERS Filling date: 9 Sep 2025 Issue date: 23 Apr 2020 | 31 Dec 2019 | 23 Apr 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers Filling date: 9 Sep 2025 Issue date: 21 Apr 2020 | 25 Sep 2019 | 21 Apr 2020 |
| Utility: Transfected T-cells and T-cell receptors for use in immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 21 Apr 2020 | 3 May 2019 | 21 Apr 2020 |
| Utility: Engineered T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 14 Apr 2020 | 5 Nov 2018 | 14 Apr 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 14 Apr 2020 | 21 May 2018 | 14 Apr 2020 |
| Utility: Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules Filling date: 9 Sep 2025 Issue date: 14 Apr 2020 | 5 Nov 2015 | 14 Apr 2020 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 9 Apr 2020 | 4 Dec 2019 | 9 Apr 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 2 Apr 2020 | 13 Dec 2019 | 2 Apr 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 2 Apr 2020 | 13 Dec 2019 | 2 Apr 2020 |
| Utility: METHOD FOR THE ABSOLUTE QUANTIFICATION OF NATURALLY PROCESSED HLA-RESTRICTED CANCER PEPTIDES Filling date: 9 Sep 2025 Issue date: 2 Apr 2020 | 15 Nov 2019 | 2 Apr 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS Filling date: 9 Sep 2025 Issue date: 26 Mar 2020 | 5 Dec 2019 | 26 Mar 2020 |
| Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, SUCH AS ACUTE MYELOID LEUKEMIA (AML) Filling date: 9 Sep 2025 Issue date: 26 Mar 2020 | 5 Dec 2019 | 26 Mar 2020 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 26 Mar 2020 | 4 Dec 2019 | 26 Mar 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 26 Sep 2019 | 24 Mar 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 25 Sep 2019 | 24 Mar 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 5 Jul 2019 | 24 Mar 2020 |
| Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 24 May 2019 | 24 Mar 2020 |
| Utility: Transfected T-cells and T-cell receptors for use in immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 16 May 2019 | 24 Mar 2020 |
| Utility: Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 10 May 2019 | 24 Mar 2020 |
| Utility: Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 20 Mar 2019 | 24 Mar 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 31 Dec 2018 | 24 Mar 2020 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 19 Mar 2020 | 22 Nov 2019 | 19 Mar 2020 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 19 Mar 2020 | 22 Nov 2019 | 19 Mar 2020 |
| Utility: RELAXIN1 DERIVED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS Filling date: 9 Sep 2025 Issue date: 19 Mar 2020 | 12 Nov 2019 | 19 Mar 2020 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 19 Mar 2020 | 12 Nov 2019 | 19 Mar 2020 |
| Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 19 Mar 2020 | 18 Sep 2019 | 19 Mar 2020 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 19 Mar 2020 | 16 Sep 2019 | 19 Mar 2020 |
| Utility: METHOD FOR HIGH THROUGHPUT PEPTIDE-MHC AFFINITY SCREENING FOR TCR LIGANDS Filling date: 9 Sep 2025 Issue date: 19 Mar 2020 | 13 Sep 2019 | 19 Mar 2020 |
| Utility: T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 17 Mar 2020 | 29 Jun 2018 | 17 Mar 2020 |
| Utility: NOVEL AND POWERFUL MHC-CLASS II PEPTIDES DERIVED FROM SURVIVIN Filling date: 9 Sep 2025 Issue date: 12 Mar 2020 | 12 Jul 2019 | 12 Mar 2020 |
| Utility: UTERINE CANCER TREATMENTS Filling date: 9 Sep 2025 Issue date: 5 Mar 2020 | 12 Nov 2019 | 5 Mar 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 3 Mar 2020 | 6 Sep 2019 | 3 Mar 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 3 Mar 2020 | 23 Jul 2019 | 3 Mar 2020 |
| Utility: Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers Filling date: 9 Sep 2025 Issue date: 3 Mar 2020 | 17 May 2018 | 3 Mar 2020 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS Filling date: 9 Sep 2025 Issue date: 27 Feb 2020 | 6 Nov 2019 | 27 Feb 2020 |
| Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS Filling date: 9 Sep 2025 Issue date: 27 Feb 2020 | 4 Nov 2019 | 27 Feb 2020 |
| Utility: Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers Filling date: 9 Sep 2025 Issue date: 25 Feb 2020 | 4 Nov 2019 | 25 Feb 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 25 Feb 2020 | 30 Aug 2019 | 25 Feb 2020 |
| Utility: Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) Filling date: 9 Sep 2025 Issue date: 25 Feb 2020 | 24 May 2019 | 25 Feb 2020 |
| Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS Filling date: 9 Sep 2025 Issue date: 20 Feb 2020 | 4 Nov 2019 | 20 Feb 2020 |
